DNA treatment could delay paralysis that strikes nearly all patients with ALS
Researchers use a DNA designer drug to restore key protein levels in motor neurons, delaying paralysis in a mouse model of ALS.
Materials provided by University of California – San Diego. Original written by Scott LaFee. Note: Content may be edited for style and length.
Source link aaaaa